751
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Revelation on the potency of α1 -blockers – parallel blockade of angiotensin II receptor: A new finding

, , &
Pages 439-442 | Received 04 May 2011, Accepted 03 Aug 2011, Published online: 02 Dec 2011

References

  • Arunlakshana O, Schild HO. (1959). Some quantitative uses of drug antagonists. Br J Pharmacol Chemother, 14, 48–58.
  • Cowley AW Jr. (1992). Long-term control of arterial blood pressure. Physiol Rev, 72, 231–300.
  • DiBona GF. (1989). Sympathetic nervous system influences on the kidney. Role in hypertension. Am J Hypertens, 2, 119S–124S.
  • Drew GM, Whiting SB. (1979). Evidence for two distinct types of postsynaptic α-adrenoceptor in vascular smooth muscle in vivo. Br J Pharmacol, 67, 207–215.
  • Du Y, Qiu J, Nelson SH, Wang DH. (1997). Regulation of type 1 ANG II receptor in vascular tissue: Role of α1-adrenoreceptor. Am J Physiol, 273, R1224–R1229.
  • Elliott WJ. (2002). Is fixed combination therapy appropriate for initial hypertension treatment? Curr Hypertens Rep, 4, 278–285.
  • Global Health Risks. (2009). Mortality and burden of disease attributable to selected major risks, WHO report, I–VI.
  • Grassi G. (2001). Renin-angiotensin-sympathetic crosstalks in hypertension: Reappraising the relevance of peripheral interactions. J Hypertens, 19, 1713–1716.
  • Hall RA. (2004). beta-adrenergic receptors and their interacting proteins. Semin Cell Dev Biol, 15, 281–288.
  • Horn PT, Kohli JD, Listinsky JJ, Goldberg LI. (1982). Regional variation in the α-adrenergic receptors in the canine resistance vessels. Naunyn Schmiedebergs Arch Pharmacol, 318, 166–172.
  • Li HT, Long CS, Gray MO, Rokosh DG, Honbo NY, Karliner JS. (1997). Cross talk between angiotensin AT1 and α1-adrenergic receptors: Angiotensin II downregulates α1a-adrenergic receptor subtype mRNA and density in neonatal rat cardiac myocytes. Circ Res, 81, 396–403.
  • Mancia G, Saino A, Grassi G. (1995). Interactions between the sympathetic nervous system and the renin-angiotensin system. In: Laragh JG, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. New York: Raven Press, 399.
  • Morphy R, Rankovic Z. (2009). Designing multiple ligands – medicinal chemistry strategies and challenges. Curr Pharm Des, 15, 587–600.
  • Paulis L, Unger T. (2010). Novel therapeutic targets for hypertension. Nat Rev Cardiol, 7, 431–441.
  • Rang HP, Dale MM, Ritter JM, Flower RJ. (2007). Pharmacology. Philadelphia, USA: Churchill Livingstone.
  • Reid IA. (1992). Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol, 262, E763–E778.
  • Reit E. (1972). Actions of angiotensin on the adrenal medulla and autonomic ganglia. Fed Proc, 31, 1338–1343.
  • Sealey JE, Laragh JH. (1995). The renin-angiotensin-aldosterone system for the normal regulation of blood pressure and sodium and potassium homeostasis. In: Laragh JG, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. New York: Raven Press, 1763–1797.
  • Shepherd JT, Mancia G. (1986). Reflex control of the human cardiovascular system. Rev Physiol Biochem Pharmacol, 105, 1–99.
  • Starke K. (1977). Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol, 77, 1–124.
  • Summers RJ. (1984). Renal α adrenoceptors. Fed Proc, 43, 2917–2922.
  • Wolff DW, Buckalew VM Jr, Strandhoy JW. (1984). Renal α1- and α2-adrenoceptor mediated vasoconstriction in dogs: Comparison of phenylephrine, clonidine, and guanabenz. J Cardiovasc Pharmacol, 6 Suppl 5, S793–S798.
  • Wolff PW, Gesek FA, Strandhoy JW. (1985). In vivo assessment of rat renal vascular α adrenoceptors [Abstract]. Fed Proc, 44, 76–92.
  • Zimmerman BG, Sybertz EJ, Wong PC. (1984). Interaction between sympathetic and renin-angiotensin system. J Hypertens, 2, 581–587.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.